EDAP TMS reported EUR1.46M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AngioDynamics USD 102K 2K Sep/2025
Boston Scientific USD 100M 4M Sep/2026
EDAP TMS EUR 1.46M 1.42M Mar/2026
Henry Schein USD 42M 1000K Sep/2026
Medtronic USD 186M 10M Jun/2026
Plus Therapeutics USD 62K 25K Dec/2023
Veracyte USD 2K 1000 Dec/2023